Victory Capital Management’s Alpine Immune Sciences, Inc. Common Stock ALPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-45,064
| Closed | -$1.79M | – | 2556 |
|
|
2024
Q1 | $1.79M | Buy |
+45,064
| New | +$1.79M | ﹤0.01% | 1490 |
|
|
2020
Q2 | – | Sell |
-3,092
| Closed | -$8K | – | 3413 |
|
|
2020
Q1 | $8K | Buy |
+3,092
| New | +$8K | ﹤0.01% | 3393 |
|
|
2019
Q4 | – | Sell |
-132,603
| Closed | -$520K | – | 3398 |
|
|
2019
Q3 | $520K | Buy |
132,603
+1,581
| +1% | +$6.2K | ﹤0.01% | 1869 |
|
|
2019
Q2 | $552K | Sell |
131,022
-3,520
| -3% | -$14.8K | ﹤0.01% | 1363 |
|
|
2019
Q1 | $923K | Sell |
134,542
-1,530
| -1% | -$10.5K | ﹤0.01% | 1261 |
|
|
2018
Q4 | $501K | Buy |
136,072
+70,980
| +109% | +$261K | ﹤0.01% | 1364 |
|
|
2018
Q3 | $412K | Sell |
65,092
-3,430
| -5% | -$21.7K | ﹤0.01% | 1474 |
|
|
2018
Q2 | $519K | Sell |
68,522
-3,780
| -5% | -$28.6K | ﹤0.01% | 1358 |
|
|
2018
Q1 | $578K | Buy |
72,302
+20,751
| +40% | +$166K | ﹤0.01% | 1331 |
|
|
2017
Q4 | $577K | Buy |
51,551
+11,799
| +30% | +$132K | ﹤0.01% | 1308 |
|
|
2017
Q3 | $461K | Buy |
39,752
+18,678
| +89% | +$217K | ﹤0.01% | 1334 |
|
|
2017
Q2 | $203K | Buy |
+21,074
| New | +$203K | ﹤0.01% | 1441 |
|